Related Experiment Video
Updated: Jun 17, 2026

Isolation of Cortical Microglia with Preserved Immunophenotype and Functionality From Murine Neonates
Published on: January 30, 2014
N-AS-triggered SPMs are direct regulators of microglia in a model of Alzheimer's disease
Ju Youn Lee1,2,3, Seung Hoon Han1,2,3, Min Hee Park1,2,3
1KNU Alzheimer's Disease Research Institute, Kyungpook National University, Daegu, 41566, South Korea.
Abstract:
Sphingosine kinase1 (SphK1) is an acetyl-CoA dependent acetyltransferase which acts on cyclooxygenase2 (COX2) in neurons in a model of Alzheimer's disease (AD). However, the mechanism underlying this activity was unexplored. Here we show that N-acetyl sphingosine (N-AS) is first generated by acetyl-CoA and sphingosine through SphK1. N-AS then acetylates serine 565 (S565) of COX2, and the N-AS-acetylated COX2 induces the production of specialized pro-resolving mediators (SPMs). In a mouse model of AD, microglia show a reduction in N-AS generation, leading to decreased acetyl-S565 COX2 and SPM production. Treatment with N-AS increases acetylated COX2 and N-AS-triggered SPMs in microglia of AD mice, leading to resolution of neuroinflammation, an increase in microglial phagocytosis, and improved memory. Taken together, these results identify a role of N-AS in the dysfunction of microglia in AD.
Related Concept Videos
Neural Regulation
Alzheimer Disease ll: Pathophysiology

